» Articles » PMID: 36834166

The Role of Preoperative Chronic Statin Therapy in Heart Transplant Receipts-A Retrospective Single-Center Cohort Study

Overview
Publisher MDPI
Date 2023 Feb 25
PMID 36834166
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Statin therapy has been proven to reduce the risk of cardiovascular events. The objective of our retrospective study was to investigate the relationship between preoperative chronic administration of statins to postoperative 2-month heart transplantation complications.

Methods: A total number of 38 heart transplantation recipients from the Cardiovascular and Transplant Emergency Institute of Târgu Mureș between May 2014 and January 2021 were included in our study.

Results: In logistic regression, we found a statistical significance between statin treatment and the presence of postoperative complications of any cause (OR: 0.06, 95% CI: 0.008-0.56; = 0.0128), simultaneously presenting an elevated risk for early-postoperative acute kidney injury (AKI). From the statin group, atorvastatin therapy had a higher risk of type 2 diabetes mellitus (T2DM) development (OR: 29.73, 95% CI: 1.19-741.76; = 0.0387) and AKI (OR: 29.73, 95% CI: 1.19-741.76; = 0.0387). C-reactive protein (CRP), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-c) represented risk factors, atorvastatin administration being independently associated with lower CRP values.

Conclusions: Chronic previous administration of statins represented a protective factor to the development of 2-month postoperative complications of any cause in heart transplant receipts.

Citing Articles

Speckle Strain Analysis of Left Ventricular Dysfunction in Paediatric Patients with Bicuspid Aortic Valve-A Pilot Study.

Fagarasan A, Ghiragosian-Rusu S, Ghiragosian C, Gozar L, Suteu C, Toma D Children (Basel). 2025; 11(12.

PMID: 39767943 PMC: 11674767. DOI: 10.3390/children11121514.


The Impact of Heart Failure Chronic Treatment Prior to Cardiac Transplantation on Early Outcomes.

Baba D, Suciu H, Avram C, Harpa M, Stoian M, Moldovan D Medicina (Kaunas). 2024; 60(11).

PMID: 39596987 PMC: 11596059. DOI: 10.3390/medicina60111801.


Tricuspid Annular Plane Systolic Excursion-to-Systolic Pulmonary Artery Pressure Ratio as a Prognostic Factor in Heart Transplant Patients.

Huma L, Suciu H, Avram C, Suteu R, Danilesco A, Baba D Medicina (Kaunas). 2024; 60(7).

PMID: 39064507 PMC: 11279045. DOI: 10.3390/medicina60071078.


A Systematic Review and Meta-Analysis of the Effects of Statin Therapy on Heart Transplantation.

Mardani-Nafchi H, Rafsanjani S, Heidari-Soureshjani S, Abbaszadeh S, Gholamine B, Naghdi N Rev Recent Clin Trials. 2024; 19(4):256-266.

PMID: 38840403 DOI: 10.2174/0115748871301446240513093612.

References
1.
McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With.... Eur Heart J. 2021; 42(48):4901. DOI: 10.1093/eurheartj/ehab670. View

2.
Ozdemir N, Elsurer R, Ibis A, Arat Z, Haberal M . Serum C-reactive protein surge in renal transplant recipients: link with allograft survival. Transplant Proc. 2007; 39(4):934-7. DOI: 10.1016/j.transproceed.2007.02.023. View

3.
Kockx M, Kritharides L . Hyperlipidaemia in immunosuppression. Curr Opin Lipidol. 2016; 27(6):631-632. DOI: 10.1097/MOL.0000000000000363. View

4.
Metra M, Ponikowski P, Dickstein K, McMurray J, Gavazzi A, Bergh C . Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2007; 9(6-7):684-94. DOI: 10.1016/j.ejheart.2007.04.003. View

5.
Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q . Perioperative Rosuvastatin in Cardiac Surgery. N Engl J Med. 2016; 374(18):1744-53. DOI: 10.1056/NEJMoa1507750. View